Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Bass, Berry & Sims Bolsters Intellectual Property Practice with Two Additions in Washington, D.C. Office

August 13, 2015

Washington, D.C./Nashville, Tenn. (August 13, 2015) – Bass, Berry & Sims PLC is pleased to announce that Janelle D. Waack has joined the firm as a member and Juhi Kaveeshvar Patel as an attorney in the firm's Intellectual Property & Technology practice, deepening the firm's experience in patent and trademark matters. Both are former examiners at the U.S. Patent and Trademark Office (USPTO) and will practice out of the firm's Washington, D.C. office.  

"Janelle is an important addition to our team of patent attorneys and greatly enhances our capabilities in the chemical, biotech and pharmaceutical arts. Her extensive experience handling patent interferences and post-grant review proceedings, managing patent prosecution and portfolio development, and counseling on all aspects of strategic IP asset management complements our existing comprehensive patent practice," said Terry Clark, member of the firm's Intellectual Property practice. 

"Juhi strengthens our existing IP practice with her trademark experience and background. Our clients will greatly benefit from the insight she provides as a former examining attorney at the USPTO. I am excited to welcome Janelle and Juhi to the firm's ever growing IP practice," said Bob Brewer, member of the firm's Intellectual Property practice.

Waack represents clients in the life sciences sector in litigation relating to patent infringement and patent validity, as well as on specialty proceedings before the USPTO Patent Trial and Appeal Board (PTAB), handling patent interferences, derivation proceedings, inter partes reviews, post grant reviews, reissuances and reexaminations.  

In Waack's 20-plus years of experience she has managed IP due diligence reviews for corporate acquisitions and other transactions, providing patent related opinions and advising clients on the strategic development and licensing of patent portfolios.  She has served as lead counsel for numerous inter partes matters before the PTAB and prevailed in complex, multi-party and multi-jurisdiction disputes, including actions before district courts and the Federal Circuit. She has extensive experience in patent interference matters, representing clients on issues of patentability, priority of invention, inventorship and ownership.  Her client list consists of companies across the life sciences sector, including pharmaceuticals, biotechnology, chemistry, agricultural products, genetically engineered crops, stem cell technology, software, unmanned aerial vehicles and medical devices.

Waack earned her bachelor's degree in chemical engineering from the University of Wisconsin at Madison and is a graduate of The George Washington University National Law Center.

Patel's practice centers on trademarks and administrative proceedings. She is a former trademark examining attorney at the USPTO, where she examined thousands of federal trademark registrations as well as defended the agency’s position, drafted briefs and prepared cases for ex parte appeals to the Trademark Trial and Appeal Board (TTAB).

Patel earned her bachelor's degree in economics and history from the University of Michigan and is a graduate of Emory University School of Law.

About Bass, Berry & Sims PLC
With more than 220 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims PLC has been involved in some of the largest and most significant business transactions and litigation matters in the country. For more information, visit www.bassberry.com.




Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.